384 related articles for article (PubMed ID: 26408505)
1. Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling.
Li W; Chen S; Li JY
Prog Neurobiol; 2015 Nov; 134():161-77. PubMed ID: 26408505
[TBL] [Abstract][Full Text] [Related]
2. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
3. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
4. Solving the puzzle of Parkinson's disease using induced pluripotent stem cells.
Zhao P; Luo Z; Tian W; Yang J; Ibáñez DP; Huang Z; Tortorella MD; Esteban MA; Fan W
Exp Biol Med (Maywood); 2014 Nov; 239(11):1421-32. PubMed ID: 24939824
[TBL] [Abstract][Full Text] [Related]
5. Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: current state and problems.
Hwang DY; Kim DS; Kim DW
J Cell Biochem; 2010 Feb; 109(2):292-301. PubMed ID: 20014069
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges.
Xiao B; Ng HH; Takahashi R; Tan EK
J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):697-702. PubMed ID: 26833176
[TBL] [Abstract][Full Text] [Related]
7. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
Cooper O; Parmar M; Isacson O
Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
[TBL] [Abstract][Full Text] [Related]
8. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
Pan-Montojo F; Funk RH
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.
Xu X; Huang J; Li J; Liu L; Han C; Shen Y; Zhang G; Jiang H; Lin Z; Xiong N; Wang T
Cell Prolif; 2016 Feb; 49(1):14-26. PubMed ID: 26748765
[TBL] [Abstract][Full Text] [Related]
10. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
11. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
Playne R; Connor B
Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
[TBL] [Abstract][Full Text] [Related]
12. Stemming the hype: what can we learn from iPSC models of Parkinson's disease and how can we learn it?
Jacobs BM
J Parkinsons Dis; 2014; 4(1):15-27. PubMed ID: 24398656
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
Stoddard-Bennett T; Reijo Pera R
Cells; 2019 Jan; 8(1):. PubMed ID: 30621042
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
[TBL] [Abstract][Full Text] [Related]
15. Progress in direct reprogramming of dopaminergic cell replacement therapy.
Zheng YY; Xu H; Wang YS
Neurol Sci; 2024 Mar; 45(3):873-881. PubMed ID: 37945931
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic differentiation using pluripotent stem cells.
Momčilović O; Montoya-Sack J; Zeng X
J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
[TBL] [Abstract][Full Text] [Related]
17. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
Marotta N; Kim S; Krainc D
Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
[No Abstract] [Full Text] [Related]
18. Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors.
Nishimura K; Murayama S; Takahashi J
Stem Cells Transl Med; 2015 Aug; 4(8):932-44. PubMed ID: 26041738
[TBL] [Abstract][Full Text] [Related]
19. Stem cell therapies for Parkinson's disease: are trials just around the corner?
Drouin-Ouellet J; Barker RA
Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
[No Abstract] [Full Text] [Related]
20. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.
Venkatesh K; Sen D
Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
